Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cantai Therapeutics
Philadelphia, Pennsylvania, United Statesalloytx.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Cantai Therapeutics is developing cytokine-targeting bispecific antibodies for autoimmune and inflammatory disorders. The company is in early development stages with no published clinical results yet.
- Therapeutic areas
- Immunology
- Modalities
- Bispecific antibodies
- Industry
- Biotech
02
Partnerships
Alloy Therapeutics (providing antibody discovery technologies)
Beyond the preview
Go deeper on Cantai Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cantai Therapeutics.